SELLAS prices $150 million common-stock offering
+1 new source since this summary was written
SELLAS Life Sciences Group set the terms of a common-stock financing at $13.00 per share for 11,538,462 shares. The transaction is expected to deliver gross proceeds of $150,000,006.00 before offering costs, and underwriters may acquire up to 1,730,769 additional shares during a 30-day period. Settlement is scheduled for November 20, 2026, subject to customary conditions.
Why it matters
The financing provides SELLAS with new capital while increasing the number of shares outstanding, reducing existing holders' proportional ownership. Exercise of the underwriters' option would create additional dilution.
Key facts
- 1SELLAS is issuing 11,538,462 common shares at $13.00 each. quiverquant.com
- 2The offering's gross proceeds are listed as $150,000,006.00. quantisnow.com
- 3Underwriters received a 30-day option for up to 1,730,769 more shares. quiverquant.com
- 4The transaction is expected to close on November 20, 2026, provided customary closing requirements are met. quiverquant.com
- 5Net proceeds to SELLAS are listed as $141,000,005.64. quantisnow.com
Summary written by AlphAI AI Desk from 7 of 7 sources. Not investment advice. Figures are as stated by the linked sources.